Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall

Journal of the American Society of Nephrology

Volumn 24, Issue 12, 2013, Pages 1981-1994

  Pletinck, Anneleen ^a   Glorieux, Griet ^a   Schepers, Eva ^a   Cohen, Gerald ^b   Gondouin, Bertrand ^c   Van Landschoot, Maria ^a   Eloot, Sunny ^a   Rops, Angelique ^d   Van De Voorde, Johan ^e   De Vriese, An ^f   Van Der Vlag, Johan ^d   Brunet, Philippe ^c   Van Biesen, Wim ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HÔPITAL DE LA CONCEPTION   (France)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

^f Renal Unit   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIDE; HEPARAN SULFATE; INDICAN; PARA CRESYLGLUCURONIDE; PARA CRESYLSULFATE; SULFATE; UNCLASSIFIED DRUG; UREMIC TOXIN; 4-CRESOL SULFATE; 4-CRESYLGLUCURONIDE; CRESOL; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL WALL; CAPILLARY LEAK SYNDROME; CHEMOTAXIS; CONTROLLED STUDY; EXTRAVASATION; GLYCOCALYX; INTRAVITAL MICROSCOPY; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CAPILLARY PERMEABILITY; CELL ADHESION; CELL COMMUNICATION; CHRONIC KIDNEY FAILURE; FEMALE; HEMODYNAMICS; IMMUNOLOGY; METABOLISM; PERITONEUM; RESPIRATORY BURST; TOXICITY; UREMIA; VASCULAR ENDOTHELIUM; VASCULARIZATION; WISTAR RAT;

ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL COMMUNICATION; CRESOLS; ENDOTHELIUM, VASCULAR; FEMALE; GLUCURONIDES; HEMODYNAMICS; INDICAN; LEUKOCYTE ROLLING; LEUKOCYTES; LIPOPOLYSACCHARIDES; PERITONEUM; RATS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC; RESPIRATORY BURST; SULFURIC ACID ESTERS; UREMIA;

EID: 84889049910     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012030281     Document Type: Article

References (82)

1. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N; European Uremic Toxin Work Group: Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20: 1048-1056, 2005
2. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999
3. Stenvinkel P: Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19: 143-151, 2001
4. Amann K, Gross ML, Ritz E: Pathophysiology underlying accelerated atherogenesis in renal disease: Closing in on the target. J Am Soc Nephrol 15: 1664-1666, 2004
5. Cheung AK, SarnakMJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362, 2000
6. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients withmoderate to severe chronic kidney disease. Kidney Int 65: 1009-1016, 2004
7. Vanholder R,De Smet R,GlorieuxG, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943, 2003
8. Glorieux G, Vanholder R: New uremic toxins - which solutes should be removed? Contrib Nephrol 168: 117-128, 2011
9. Brunet P, Gondouin B, Duval-Sabatier A, Dou L, Cerini C, Dignat- George F, Jourde-Chiche N, Argiles A, Burtey S: Does uremia cause vascular dysfunction? Kidney Blood Press Res 34: 284-290, 2011
10. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P: Protein-bound toxins-update 2009. Semin Dial 22: 334- 339, 2009
11. Liabeuf S, Drüeke TB, Massy ZA: Protein-bound uremic toxins: New insight from clinical studies. Toxins (Basel) 3: 911-919, 2011
12. Vanholder R, Schepers E, Pletinck A, Neirynck N, GlorieuxG: An update on protein-bound uremic retention solutes. J Ren Nutr 22: 90-94, 2012
13. De Vriese AS, Lameire NH: Intravital microscopy: An integrated evaluation of peritoneal function and structure.NephrolDial Transplant 16: 657-660, 2001
14. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P: The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 5: 1302-1308, 2007
15. Masai N, Tatebe J, Yoshino G, Morita T: Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-kB pathway. Circ J 74: 2216-2224, 2010
16. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J ThrombHaemost 4: 566-573, 2006
17. Yamamoto H, Tsuruoka S, Ioka T, Ando H, Ito C, Akimoto T, Fujimura A, Asano Y, Kusano E: Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69: 1780-1785, 2006
18. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65: 442-451, 2004
19. Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Wang BH, Krum H: Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J 31: 1771-1779, 2010
20. Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M, Yamato H, Kurokawa K, Fukagawa M: Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71: 738-743, 2007
21. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R: P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22: 592-596, 2007
22. Meert N, Schepers E, Glorieux G, Van Landschoot M, Goeman JL, Waterloos MA, Dhondt A, Van der Eycken J, Vanholder R: Novel method for simultaneous determination of p-cresylsulphate and pcresylglucuronide: Clinical data and pathophysiological implications. Nephrol Dial Transplant 27: 2388-2396, 2012
23. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54: 891-901, 2009
24. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uremic Toxin Work Group (EUTox): Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4: 1551-1558, 2009
25. Lee CT, Kuo CC, Chen YM, Hsu CY, Lee WC, Tsai YC, Ng HY, Kuo LC, Chiou TT, Yang YK, Cheng BC, Chen JB: Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis. Perit Dial Int 30: 456-463, 2010
26. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P: Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73: 1174-1180, 2008
27. De Smet R, Van Kaer J, Van VlemB, De Cubber A, Brunet P, Lameire N, Vanholder R: Toxicity of free p-cresol: A prospective and cross-sectional analysis. Clin Chem 49: 470-478, 2003
28. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uraemic Toxin Work Group (EUTox): Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25: 1183-1191, 2010
29. Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS: Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-a prospective cohort study. Nephrol Dial Transplant 27: 1169-1175, 2012
30. Wang CP, Lu LF, Yu TH, Hung WC, Chiu CA, Chung FM, Yeh LR, Chen HJ, Lee YJ, Houng JY: Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure. Atherosclerosis 211: 579-583, 2010
31. Massy ZA, Barreto DV, Barreto FC, Vanholder R: Uraemic toxins for consideration by the cardiologist-Beyond traditional and non-traditional cardiovascular risk factors. Atherosclerosis 211: 381-383, 2010
32. Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T: Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol 31: 435-441, 2010
33. Ito S,OsakaM,Higuchi Y,Nishijima F, IshiiH, YoshidaM: Indoxyl sulfate induces leukocyte-endothelial interactions through upregulation of E-selectin. J Biol Chem 285: 38869-38875, 2010
34. Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, Alvarez- Cardona JA, Pruitt IE, Rhee EP, Colvin RA, Gerszten RE: Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem284: 19189-19195, 2009
35. Schmid-Schönbein GW: Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 46: 2397-2401, 1987
36. Alom-Ruiz SP, Anilkumar N, Shah AM: Reactive oxygen species and endothelial activation. Antioxid Redox Signal 10: 1089-1100, 2008
37. Davies PF, Barbee KA, Lal R, Robotewskyj A,GriemML:Hemodynamics and atherogenesis. Endothelial surface dynamics in flow signal transduction. Ann N Y Acad Sci 748: 86-102, 1995
38. Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA 282: 2035-2042, 1999
39. Gross PL, Aird WC: The endothelium and thrombosis. Semin Thromb Hemost 26: 463-478, 2000
40. Gondouin B, Cerini C, Dou L, Sallée M, Duval-Sabatier A, Pletinck A, Calaf R, Lacroix R, Jourde-Chiche N, Poitevin S, Arnaud L, Vanholder R, Brunet P, Dignat-George F, Burtey S: Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway [published online ahead of printMay 1, 2013]. Kidney Int 10.1038/ki.2013.133
41. Mercier E, Branger B, Vecina F, Al-Sabadani B, Berlan J, Dauzat M, Fourcade J, Gris JC: Tissue factor coagulation pathway and blood cells activation state in renal insufficiency. Hematol J 2: 18-25, 2001
42. Pawlak K, Mysliwiec M, Pawlak D: Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients. Thromb Haemost 102: 49-55, 2009
43. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, Dignat-George F: Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99: 3962-3970, 2002
44. Gouverneur M, Berg B, Nieuwdorp M, Stroes E, Vink H: Vasculoprotective properties of the endothelial glycocalyx: Effects of fluid shear stress. J Intern Med 259: 393-400, 2006
45. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES: The endothelial glycocalyx: A potential barrier between health and vascular disease. Curr Opin Lipidol 16: 507-511, 2005
46. Constantinescu AA, Vink H, Spaan JA: Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 23: 1541-1547, 2003
47. Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, Tarbell JM: Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 93: e136-e142, 2003
48. Mochizuki S, Vink H, Hiramatsu O, Kajita T, Shigeto F, Spaan JA, Kajiya F: Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium- derived nitric oxide release. Am J Physiol Heart Circ Physiol 285: H722-H726, 2003
49. Reitsma S, Slaaf DW, Vink H, van ZandvoortMA, oude EgbrinkMG: The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Arch 454: 345-359, 2007
50. Chappell D, Hofmann-Kiefer K, JacobM, RehmM, Briegel J,Welsch U, Conzen P, Becker BF: TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 104: 78-89, 2009
51. Vink H, Constantinescu AA, Spaan JA: Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet-endothelial cell adhesion. Circulation 101: 1500-1502, 2000
52. Lipowsky HH: The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng 40: 840-848, 2012
53. Vlahu CA, Lemkes BA, Struijk DG, Koopman MG, Krediet RT, Vink H: Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol 23: 1900-1908, 2012
54. Stenvinkel P, Carrero JJ, Axelsson J, LindholmB, HeimbürgerO, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3: 505-521, 2008
55. Schepers E, Barreto DV, Liabeuf S, Glorieux G, Eloot S, Barreto FC, Massy Z, Vanholder R; European Uremic Toxin Work Group (EUTox): Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 6: 2374-2383, 2011
56. Stenvinkel P: Endothelial dysfunction and inflammation-is there a link? Nephrol Dial Transplant 16: 1968-1971, 2001
57. Singh A, Ramnath RD, Foster RR, Wylie EC, Fridén V, Dasgupta I, Haraldsson B, Welsh GI, Mathieson PW, Satchell SC: Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One 8: e55852, 2013
58. van Golen RF, van Gulik TM, Heger M: Mechanistic overview of reactive species-induceddegradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 52: 1382-1402, 2012
59. Itoh Y, EzawaA, KikuchiK, Tsuruta Y, NiwaT: Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 403: 1841-1850, 2012
60. BrueggerD, JacobM, Rehm M, LoetschM,Welsch U, Conzen P, Becker BF: Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 289: H1993-H1999, 2005
61. Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, Smith LP, Cheng SS, Overdier KH, Thompson KR, Geraci MW, Douglas IS, Pearse DB, Tuder RM: The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18: 1217-1225, 2012
62. Ostrowski SR, Pedersen SH, Jensen JS, Mogelvang R, Johansson PI: Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 17: R32, 2013
63. Desjardins C, Duling BR: Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol 258: H647-H654, 1990
64. Vink H, Wieringa PA, Spaan JA: Evidence that cell surface charge reduction modifes capillary red cell velocity-flux relationships in hamster cremaster muscle. J Physiol 489: 193-201, 1995
65. MulivorAW, LipowskyHH: Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 283: H1282-H1291, 2002
66. Mulivor AW, Lipowsky HH: Inhibition of glycan shedding and leukocyte- endothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirculation 16: 657-666, 2009
67. Rops AL, Jacobs CW, Linssen PC, Boezeman JB, Lensen JF,Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, van der Vlag J, Berden JH: Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes. Nephrol Dial Transplant 22: 1070-1077, 2007
68. Eriksson EE: Intravital microscopy on atherosclerosis in apolipoprotein e-deficient mice establishes microvessels as major entry pathways for leukocytes to advanced lesions. Circulation 124: 2129-2138, 2011
69. Ley K, Gaehtgens P: Endothelial, not hemodynamic, differences are responsible for preferential leukocyte rolling in rat mesenteric venules. Circ Res 69: 1034-1041, 1991
70. Eriksson EE, Karlof E, Lundmark K, Rotzius P, Hedin U, Xie X: Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol 25: 723-728, 2005
71. De Vriese AS, Verbeuren TJ, Vallez MO, Lameire NH, De Buyzere M, Vanhoutte PM: Off-line analysis of red blood cell velocity in renal arterioles. J Vasc Res 37: 26-31, 2000
72. Geerts AM, Cheung KJ, Van Vlierberghe H, De Vriese AS, Mortier S, Vanheule E, Lameire N, De Vos M, Colle I: Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon: An in vivo study. J Hepatol 46: 804-815, 2007
73. Woodman RC, Teoh D, Payne D, Kubes P: Thrombin and leukocyte recruitment in endotoxemia. Am J Physiol Heart Circ Physiol 279: H1338-H1345, 2000
74. Hickey MJ, Granger DN, Kubes P: Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: Studies in iNOSdeficient mice. Acta Physiol Scand 173: 119-126, 2001
75. Feigenbaum J, Neuberg CA: Simplified method for the preparation of aromatic sulfuric acid esters. J Am Chem Soc 63: 3529-3530, 1941
76. Van der Eycken E, Terryn N, Goeman JL, Carlens G, Nerinckx W, Claeyssens M, Van der Eycken J, VanMontaguM, Brito-AriasM, Engler G: Sudan-beta-D- glucuronides and their use for the histochemical localization of beta-glucuronidase activity in transgenic plants. Plant Cell Rep 19: 966-970, 2000
77. Pletinck A, Consoli C, Van Landschoot M, Steppan S, Topley N, Passlick-Deetjen J, Vanholder R, Van Biesen W: Salt intake induces epithelial-to-mesenchymal transition of the peritoneal membrane in rats. Nephrol Dial Transplant 25: 1688-1696, 2010
78. Rops AL, van den HovenMJ, BaselmansMM, Lensen JF,Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, Berden JH, van der Vlag J: Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. Kidney Int 73: 52-62, 2008
79. van den Born J, Gunnarsson K, Bakker MA, Kjellén L, Kusche-Gullberg M, Maccarana M, Berden JH, Lindahl U: Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem270: 31303-31309, 1995
80. Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R: Effective removal of protein-bound uraemic solutes by different convective strategies: A prospective trial. Nephrol Dial Transplant 24: 562-570, 2009
81. Cohen G, Hörl WH: Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions. Eur J Clin Invest 34: 774-781, 2004
82. Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J: Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation. Cardiovasc Res 76: 149-159, 2007